Global Hip Implant Market Outlook 2018-2023

The 'Global Hip Implant Market Outlook 2018-2023' offers detailed coverage of hip implant industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading hip implant producers to provide exhaustive coverage of the market for hip implant. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography.

The report has been prepared based on an in-depth market analysis with inputs from key industry participants. The global hip implant market has been segmented into five major regions, namely, North America (U.S., Canada, and others), Europe (U.K., France, Germany, Russia, and others), Asia-Pacific (China, Japan, India, Australia, and others), South America (Brazil, Argentina, and others), and Middle East & Africa (South Africa, Saudi Arabia, and others). Furthermore, the report also includes an in-depth competitive analysis of the key vendors operating in this market.

Key Regions
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America

Key Vendors
- DePuy Synthes, Inc. (Johnson & Johnson)
- Smith & Nephew plc
- Stryker Corporation
- Corentec Company Ltd.
- ConforMIS, Inc.
- Corin Group
- Zimmer Biomet Holdings, Inc.
- B. Braun Melsungen AG
- DJO Global, Inc.
- request free sample to get a complete list of companies

Key Questions Answered in This Report
- Analysis of the hip implant market including revenues, future growth, market outlook
- Historical data and forecast
- Regional analysis including growth estimates
- Analyzes the end user markets including growth estimates.
- Profiles on hip implant vendors including products, sales/revenues, SWOT, and market position, recent developments.
- Market structure, market drivers and restraints.

Part 1. Summary

Part 2. Report Methodology
2.1 Methodology
2.2 Data Source

Part 3. Introduction

Part 4. Industry Value Chain
4.1 Hip Implant Industry Value Chain Analysis
4.2 Upstream
4.3 End-uses
4.4 Distributors

Part 5. Competitive Landscape
5.1 Global Hip Implant Sales & Share by Company (2013-2018)
5.2 Global Hip Implant Revenue & Share by Company (2013-2018)
5.3 Pricing Trends
5.4 Competitive Trends

Part 6. Segmentation by Type
6.1 Global Hip Implant Sales Volume by Type (2013-2018)
6.2 Global Hip Implant Revenue by Type (2013-2018)
6.3 Global Hip Implant Price by Type (2013-2018)

Part 7. Segmentation by Application
7.1 Global Hip Implant Sales Volume by Application (2013-2018)
7.2 Global Hip Implant Revenue by Application (2013-2018)
7.3 Global Hip Implant Price by Application (2013-2018)

Part 8. Regional Perspectives
8.1 Overview
8.2 North America
8.2.1 Market Size (Volume & Value)
8.2.2 by Application
8.2.3 by Country (U.S., Canada, Mexico, etc.)

8.3 Europe
8.3.1 Market Size (Volume & Value)
8.3.2 by Application
8.3.3 by Country (Germany, UK, France, Spain, Italy, etc.)

8.4 Asia-Pacific
8.4.1 Market Size (Volume & Value)
8.4.2 by Application
8.4.3 by Country (China, Japan, Korea, India, etc.)

8.5 Middle East & Africa
8.5.1 Market Size (Volume & Value)
8.5.2 by Application
8.5.3 by Country (Saudi Arabia, Turkey, Nigeria, Iran, South Africa, etc.)

8.6 South America
8.6.1 Market Size (Volume & Value)
8.6.2 by Application
8.6.3 by Country (Brazil, Argentina, Colombia, etc.)

Part 9. Company Profiles
9.1 Company Profile
9.2 Product Offered
9.3 Business Performance
9.4 Recent Developments

Part 10. Market Forecast
10.1 Global Hip Implant Market Size Forecast (2018-2023)
10.1.1 Global Hip Implant Sales Forecast (2018-2023)
10.1.2 Global Hip Implant Revenue Forecast (2018-2023)
10.2 Forecast by Region
10.2.1 North America
10.2.2 Europe
10.2.3 Asia-Pacific
10.2.4 Middle East & Africa
10.2.5 South America
10.3 Forecast by Type
10.4 Forecast by Application

Part 11. Market Drivers
11.1 Opportunities
11.2 Challenges
11.3 Economic/Political Environmental

Part 12. Industry Activity
12.1 M&As, JVs and Partnership
12.2 Other Developments

Part 13. Appendix
DISCLAIMER
ABOUT GEN CONSULTING COMPANY